Winter CME Series: Emerging Paradigms in the Management of Oncology Patients

The University of Illinois Cancer Center is hosting its second annual Winter CME Series. Join us January 29 for Session 3 of the three-part series. Earn up to three hours of CME per session. The series is accredited by Global Education Group.

Register at the conference website: cmersvp.com/uicmew

The series’ target audience includes medical oncologists, hematologists, pathologists, oncology nurses, fellows, residents, advanced practice providers, family practitioners, primary care practitioners, allied health professionals and other providers interested in the care of patients with cancer.

PRELIMINARY SESSION AGENDA
1 – 2 p.m. Registration, Exhibits and Lunch
2 – 2:05 p.m. Introduction
2:05 – 3 p.m. Innovative T-Cell Engagers and Adoptive T-Cell Therapies in Lung Cancer, Melanoma, and Soft Tissue Sarcoma (VK Gadi, MD, PhD – University of Illinois Cancer Center and Kai He, MD, PhD – Ohio State University Comprehensive Cancer Center)
3 – 3:40 p.m. Approved and Emerging Diagnostics for Early Cancer Detection and Minimal Residual Disease in Colon and Lung Cancer (Gayatry Mohapatra, PhD – University of Illinois Cancer Center)
3:40 – 4:40 p.m. Break, Exhibits, Non-CME Ancillary Event, Afternoon Pick Me Up
4:40 – 5:25 p.m. Principles of Antibody-Drug Conjugate Therapy and Current Approved Indications in Lung and Ovarian Cancer (Rajat Thawani, MBBS – University of Chicago)
5:25 – 6 p.m. Health Equity – Discuss limitations of current registrational studies as they apply to minority populations and FDA guidance for improving this racial disparity (Ameen Salahudeen, MD, PhD – University of Illinois Cancer Center)
6 – 7 p.m. Exhibits

SERIES COURSE CHAIR
Matias E Sanchez, MD
Assistant Professor of Medicine
UI Health Division Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL

SESSION 3 CHAIR
Ameen Salahudeen, MD, PhD
Assistant Professor
Division of Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL

FACULTY PRESENTERS
VK Gadi, MD, PhD
Professor and Director of Medical Oncology
UI Health Division of Hematology/Oncology
Deputy Director
University of Illinois Cancer Center
Chicago, IL

Kai He, MD, PhD
Assistant Professor
Ohio State University Comprehensive Cancer Center
Columbus, OH

Gayatry Mohapatra, PhD
Assistant Professor of Pathology
University of Illinois Cancer Center
Chicago, IL

Ameen Salahudeen, MD, PhD
Assistant Professor
University of Illinois Cancer Center
Chicago, IL

Rajat Thawani, MBBS
Assistant Professor
University of Chicago
Chicago, IL

EDUCATIONAL GOAL
This conference aims to educate practitioners and update their knowledge of advances in diagnostic modalities in oncology.

LEARNING OBJECTIVES
After participating in these activities, learners will be better able to understand:
• Limitations of current registrational studies as they apply to minority populations and FDA guidance for improving this racial disparity (health equity)
• Principles of antibody-drug conjugate therapy and current approved indications
• Principles of biological cell engagers/cell therapies and current approved indications
• Currently approved and emerging diagnostics for early cancer detection and minimal residual disease